These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Tetrahydroaminoacridine potentiates neurotoxicity of quinolinic acid in rat striatum. Zhu SG, McGeer EG, Singh EA, McGeer PL. Neurosci Lett; 1988 Dec 19; 95(1-3):252-6. PubMed ID: 2976129 [Abstract] [Full Text] [Related]
3. Lamotrigine protects against kainate but not ibotenate lesions in rat striatum. McGeer EG, Zhu SG. Neurosci Lett; 1990 May 04; 112(2-3):348-51. PubMed ID: 2141673 [Abstract] [Full Text] [Related]
4. Effect of MK-801, kynurenate, glycine, dextrorphan and 4-acetylpyridine on striatal toxicity of quinolinate. Zhu SG, McGeer EG, McGeer PL. Brain Res; 1989 Mar 06; 481(2):356-60. PubMed ID: 2524238 [Abstract] [Full Text] [Related]
5. Dextromethorphan does not protect against quinolinic acid neurotoxicity in rat striatum. Engber TM, Chase TN. Neurosci Lett; 1988 Dec 19; 95(1-3):269-74. PubMed ID: 2976130 [Abstract] [Full Text] [Related]
6. Kynurenic acid blocks neurotoxicity and seizures induced in rats by the related brain metabolite quinolinic acid. Foster AC, Vezzani A, French ED, Schwarcz R. Neurosci Lett; 1984 Aug 10; 48(3):273-8. PubMed ID: 6237279 [Abstract] [Full Text] [Related]
7. On the excitotoxic properties of quinolinic acid, 2,3-piperidine dicarboxylic acids and structurally related compounds. Foster AC, Collins JF, Schwarcz R. Neuropharmacology; 1983 Dec 10; 22(12A):1331-42. PubMed ID: 6229703 [Abstract] [Full Text] [Related]
8. Systemic treatments with GM1 ganglioside reduce quinolinic acid-induced striatal lesions in the rat. Lombardi G, Zanoni R, Moroni F. Eur J Pharmacol; 1989 Dec 12; 174(1):123-5. PubMed ID: 2612575 [Abstract] [Full Text] [Related]
9. Idebenone attenuates neuronal degeneration induced by intrastriatal injection of excitotoxins. Miyamoto M, Coyle JT. Exp Neurol; 1990 Apr 12; 108(1):38-45. PubMed ID: 2138566 [Abstract] [Full Text] [Related]
10. The organotypic tissue culture model of corticostriatal system used for examining amino acid neurotoxicity and its antagonism: studies on kainic acid, quinolinic acid and (-) 2-amino-7-phosphonoheptanoic acid. Whetsell WO, Schwarcz R. J Neural Transm Suppl; 1983 Apr 12; 19():53-63. PubMed ID: 6321650 [Abstract] [Full Text] [Related]
11. Prolonged infusion of quinolinic acid into rat striatum as an excitotoxic model of neurodegenerative disease. Susel Z, Engber TM, Kuo S, Chase TN. Neurosci Lett; 1991 Jan 02; 121(1-2):234-8. PubMed ID: 1826944 [Abstract] [Full Text] [Related]
12. Neurotoxicity induced by continuous infusion of quinolinic acid into the lateral ventricle in rats. Yamada K, Fuji K, Nabeshima T, Kameyama T. Neurosci Lett; 1990 Oct 02; 118(1):128-31. PubMed ID: 2147984 [Abstract] [Full Text] [Related]
13. The neurotoxic actions of quinolinic acid in the central nervous system. el-Defrawy SR, Boegman RJ, Jhamandas K, Beninger RJ. Can J Physiol Pharmacol; 1986 Mar 02; 64(3):369-75. PubMed ID: 2939936 [Abstract] [Full Text] [Related]
15. Striatal grafts provide sustained protection from kainic and quinolinic acid-induced damage. Tulipan N, Luo SQ, Allen GS, Whetsell WO. Exp Neurol; 1988 Dec 27; 102(3):325-32. PubMed ID: 2973990 [Abstract] [Full Text] [Related]
16. Ethanol, baclofen, and kainic acid neurotoxicity. McGeer EG, Jakubovic A, Singh EA. Exp Neurol; 1980 Aug 27; 69(2):359-64. PubMed ID: 7409049 [No Abstract] [Full Text] [Related]